Increasing Demand for Facial Fat Transfer Treatment is Set to Propel the Growth of the Global Facial Fat Transfer Market at a CAGR of 11.05 %

Pune, India, December 2022, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Facial Fat Transfer Market.

Market Highlights

Facial Fat Transfer Market is estimated to be valued at USD 5687.63 Million by 2030and is expected to register a CAGR of 11.05% during the forecast period.

Facial fat transfer is a minimally invasive surgical procedure to move fat from an area of the body where it is plentiful and transfer it to the face to restore lost volume. The fat is gently removed using modern liposuction techniques and is then prepared for injecting into the face. Several dermal fillers are available in the market, designed to improve different parts of the face.

Segment Analysis

The Global Facial Fat Transfer Market has been segmented based on the target area, Treatment, End-User, and Region. Based on the target area, the market has been divided into naso-labial folds, lips, marionette folds, temples, chin, and under-eye area. Based on treatment, the market is further sub-segmented as dermal fillers, fat injections, and others. On the basis of end user, the market has been divided into hospitals, cosmetic surgery clinics, and others.

Regional Analysis

Geographically, the Global Facial Fat Transfer Market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. As per MRFR analysis, Americas were the largest market for facial fat transfer in 2018 and is expected to remain dominant during the review period. Increasing awareness regarding body aesthetics and the introduction of advanced technology in the facial rejuvenation industry are major factors that drive the growth of the facial fat transfer market in the American region.

Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The increasing demand for minimally invasive cosmetic procedures is fueling the facial fat transfer market growth in European countries. For instance, according to the British Association of Aesthetic Plastic Surgeons, in London, 2019, over 28,000 cosmetic procedures took place in 2018.

The market in Asia-Pacific is expected to register a significant growth rate during the forecast period. The majority of the companies in Asia-Pacific are committed to investing in research and development of facial fat transfer treatments, which will ultimately boost the growth of the market.

The growth of the Middle East and Africa facial fat transfer market is majorly attributed to developing healthcare infrastructure, and continuously increasing demand for facial fat transfer products. Africa holds the least share of the market due to the limited availability of funds and medical facilities.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Facial Fat Transfer Market Research Report

Market Players

Market Research Future (MRFR) recognizes DR. Korman (Israel), Galderma Laboratories, L.P. (US), Integra LifeSciences Corporation (Israel), Merz Pharma (Germany), Allergan (Ireland), SciVision Biotech Inc (Taiwan), Suneva Medical, Inc (US), Bausch Health Companies Inc (Canada), Teoxane Laboratories (Switzerland), Ipsen Pharma (France), Sinclair Pharma (UK) as the key players in the Global Facial Fat Transfer Market.

Key Findings of the Study:

• The Global Facial Fat Transfer Market is projected to reach over USD 5687.63 Million by 2030 at an 11.05 % CAGR during the review period of 2022 to 2030.

• North America accounted for the largest market share, with the US being the major contributor to the growth of the market.

• Based on the target area, the naso-labial folds segment is projected to register the highest CAGR of 11.05% during the forecast period owing to the rising prevalence of facial fat transfer cases.

• On the basis of treatment, the dermal fillers segment accounted for the largest market share of 49.76% in 2018.

• Based on end user, the hospitals segment accounted for the largest market share of 49.20% in 2018